
Tom Fitton @TomFitton
BREAKING: "Postmarketing data demonstrate increased risks of myocarditis and pericarditis, particularly within 7 days following second dose. Observed risk is higher among males under 40 than among females and older males. The observed risk is highest in males 18 through 24." — PolitiTweet.org
Moderna @moderna_tx
BREAKING: The @FDA has approved the Biologics License Application (BLA) for SPIKEVAX™ (COVID-19 Vaccine, mRNA) to p… https://t.co/LQCZVdNrrq